Ustekinumab treatment for neutrophilic dermatoses associated with Crohn's disease: A multicenter retrospective study.
| Publicado en: | Journal of the American Academy of Dermatology Vol. 80; no. 3; pp. 781 - 785 |
|---|---|
| Autores principales: | , , , , , , , , , , |
| Formato: | research Journal Article |
| Publicado: |
Elsevier B.V.
Mar2019
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=134616024&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 134616024 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 01909622 1ZF jtl: Journal of the American Academy of Dermatology issn: 01909622 maglogo: N pubinfo: dt: Mar2019 vid: 80 iid: 3 pid: 467 pub: Elsevier B.V. place: New York, New York artinfo: ui: 134616024 134616024 NLM30003991 134616024 10.1016/j.jaad.2018.06.065 NLM30003991 134616024 ppf: 781 ppct: 4 formats: tig: atl: Ustekinumab treatment for neutrophilic dermatoses associated with Crohn's disease: A multicenter retrospective study. aug: au: de Risi-Pugliese, Tullia Seksik, Philippe Bouaziz, Jean-David Chasset, François Moguelet, Philippe Gornet, Jean-Marc Bourrier, Anne Amiot, Aurélien Beaugerie, Laurent Francès, Camille Guégan, Sarah affil: AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France sug: subj: Crohn Disease Drug Therapy Sweet's Syndrome Drug Therapy Dermatologic Agents Therapeutic Use Pyoderma Gangrenosum Drug Therapy Sweet's Syndrome Complications Pyoderma Gangrenosum Complications Young Adult Female Crohn Disease Complications Male Human Child Adult Adolescence Retrospective Design Validation Studies Comparative Studies Evaluation Research Multicenter Studies Child: 6-12 years Adult: 19-44 years Adolescent: 13-18 years Female Male pubtype: Academic Journal doctype: research Journal Article ougenre: Unknown ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|